Literature DB >> 19435834

Inflammation-dependent expression of SPARC during development of chronic pancreatitis in WBN/Kob rats and a microarray gene expression analysis.

T Reding1, U Wagner, A B Silva, L-K Sun, M Bain, S-Y Kim, D Bimmler, R Graf.   

Abstract

The pathophysiology of human chronic pancreatitis is not well understood and difficult to follow on a molecular basis. Therefore, we used a rat model [Wistar-Bonn/Kobori (WBN/Kob)] that exhibits spontaneous chronic inflammation and fibrosis in the pancreas. Using microarrays we compared gene expression patterns in the pancreas during development of inflammation and fibrosis of WBN/Kob rats with age-matched healthy Wistar rats. The extracellular matrix protein SPARC (secreted protein, acidic, and rich in cysteines) and other transcripts of inflammatory genes were quantified by real-time PCR, and some were localized by immunohistochemistry. When pancreatic inflammation becomes obvious at the age of 16 wk, several hundred genes are increased between 3- and 50-fold in WBN/Kob rats compared with healthy Wistar rats. Proteins produced by acinar cells and characteristic for inflammation, e.g., pancreatitis-associated protein, are highly upregulated. Other proteins, derived from infiltrating inflammatory cells and from activated stellate cells (fibrosis) such as collagens and fibronectins are also significantly upregulated. SPARC was localized to acinar cells where it increased in the vicinity of inflammatory foci. However, acinar expression of SPARC was lost during destruction of acinar cells. In human pancreatic specimens with chronic pancreatitis, SPARC exhibited a similar expression profile. During chronic inflammation and fibrosis in the WBN/Kob rat, inflammatory genes, growth factors, and structural genes exhibit a high increase of expression. A temporal profile including pre- and postinflammatory phases indicates a concurrent activation of inflammatory and fibrotic changes. Inflammation dependent expression of SPARC appears to be lost during acinar-to-duct metaplasia both in rat and human pancreas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435834     DOI: 10.1152/physiolgenomics.00028.2009

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  9 in total

Review 1.  SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.

Authors:  Ferda Kaleağasıoğlu; Martin R Berger
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 2.  SPARC: a key player in the pathologies associated with obesity and diabetes.

Authors:  Katarina Kos; John P H Wilding
Journal:  Nat Rev Endocrinol       Date:  2010-03-02       Impact factor: 43.330

3.  Activity of acute pancreatitis is modified by secreted protein acidic and rich in cysteine ablation.

Authors:  Christoph Ammer-Herrmenau; Laurin Wolf; Syeda S Nasrin; Iswarya Ramu; Roberta Roggiolani; Robert G Goetze; Soeren M Buchholz; Mathias Sendler; Volker Ellenrieder; Albrecht Neesse
Journal:  United European Gastroenterol J       Date:  2022-06-14       Impact factor: 6.866

4.  Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.

Authors:  Jiu-Cun Wang; Syeling Lai; Xinjian Guo; Xuefeng Zhang; Benoit de Crombrugghe; Sonali Sonnylal; Frank C Arnett; Xiaodong Zhou
Journal:  Arthritis Res Ther       Date:  2010-04-01       Impact factor: 5.156

5.  SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.

Authors:  Angela Chew; Paul Salama; Anneli Robbshaw; Borut Klopcic; Nikolajs Zeps; Cameron Platell; Ian C Lawrance
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

6.  Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats.

Authors:  Kanikkai Raja Aseer; Sang Woo Kim; Myung-Sook Choi; Jong Won Yun
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

7.  The pancreas responds to remote damage and systemic stress by secretion of the pancreatic secretory proteins PSP/regI and PAP/regIII.

Authors:  Theresia Reding; Cristian Palmiere; Clinsyjos Pazhepurackel; Marc Schiesser; Daniel Bimmler; Andrea Schlegel; Ursula Süss; Sabrina Steiner; Leandro Mancina; Gitta Seleznik; Rolf Graf
Journal:  Oncotarget       Date:  2017-05-02

8.  The unique pancreatic stellate cell gene expression signatures are associated with the progression from acute to chronic pancreatitis.

Authors:  Cheng Hu; Liyuan Yin; Zhiyao Chen; Richard T Waldron; Aurelia Lugea; Yiyun Lin; Xiaoqian Zhai; Li Wen; Yuan-Ping Han; Stephen J Pandol; Lihui Deng; Qing Xia
Journal:  Comput Struct Biotechnol J       Date:  2021-11-26       Impact factor: 7.271

9.  Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma.

Authors:  Christopher Hartley; Daniel Rowan; Xiuxu Chen; Luisa Gomez-Arellano; Anna Marie West; Kiyoko Oshima; Alexander Craig Mackinnon
Journal:  Pract Lab Med       Date:  2020-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.